Atlas Trials

Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or More

Clinical trial NCT06954818 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06954818
Sponsor
CSPC Megalith Biopharmaceutical Co.,Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2025-05-10
Primary completion
2025-12-10
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.